Novo Next-Generation Obesity Shot Falls Short of Lilly Rival
Original Report
Novo Nordisk’s next-generation obesity shot delivered less weight loss than Eli Lilly rival blockbuster in yet another blow to the Danish company’s attempts to regain lost ground in the weight-loss...
Novo Nordisk’s next-generation obesity shot delivered less weight loss than Eli Lilly rival blockbuster in yet another blow to the Danish company’s attempts to regain lost ground in the weight-loss market. People treated with a standard dose of Novo’s CagriSema in a trial achieved 20.2% weight loss after 84 weeks, compared with 23.6% for Lilly’s tirzepatide. Sam Fazeli of Bloomberg Intelligence joins to discuss. He also breaks down how Merck is splitting its main pharmaceutical unit in two in an effort to better highlight the parts of the business that are growing, as it stares down a patent cliff for its best-selling cancer drug Keytruda. (Source: Bloomberg)
Glass House Analysis
Corporate decisions reverberate through local communities—a merger might mean headquarters relocating, a restructuring could eliminate jobs, and strategic shifts affect suppliers and service providers in countless towns. Behind quarterly earnings numbers are real employment decisions, investment choices, and community impacts that shape the economic landscape of regions across the country.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Mortgage rates just dropped below 6%, matching lowest level since 2022
Mortgage rates dropped below 6%, matching their lowest levels since 2022, as economic concerns over tariffs and a recent GDP report cause bond yields to drop.
Congress must enact Trump’s tariffs now to steer the U.S. from a massive revenue cliff
Tariffs need to become law or the federal budget will take a hit. Lawmakers have less than 150 days to decide.
How Domino's is trying to double its business during a rough patch for big pizza rivals
Domino's Pizza posted better-than-expected earnings and said it is winning over lower-income diners with value offerings.
Airlines cancel thousands of flights as blizzard cripples East Coast airports
American, Delta, JetBlue, United and others waived change and cancellation fees ahead of another massive winter storm.